AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JAN 8 - (NewsRx.com & NewsRx.net) -- Pravastatin, a statin drug used to reduce cholesterol, does not reduce the death rate or incidence of coronary heart disease events in patients with moderately high cholesterol and well-controlled high blood pressure, when compared to usual care, according to researchers in Texas and Washington.
The role levels of low-density lipoprotein cholesterol (LDL-C, the "bad" cholesterol) play in the development of coronary heart disease (CHD) is well-established. Trials in the 1970s and 1980s showed that lowering LDL-C reduced the incidence of CHD-related events such as heart attack, but the average reduction in LDL-C for these trials was only 10%.
In the 1980s, a more powerful class of drugs, statins, were developed which could reduce total cholesterol by approximately 20% or more. Studies have demonstrated that statins administered to individuals with risk factors for CHD reduce CHD events. However, many of these…
Source: HighBeam Research, Statin no better than usual care in reducing risk of morbidity,...